AC
TEVA icon

AXQ Capital’s Teva Pharmaceuticals TEVA Stock Holding History

AXQ Capital’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-15,600
Closed -$220K – 724
2024
Q1 		$220K Buy
15,600
+300
+2% +$3.78K 0.05% 499
2023
Q4 		$160K Sell
15,300
-12,800
-46% -$120K 0.04% 566
2023
Q3 		$287K Buy
28,100
+5,300
+23% +$49.4K 0.1% 321
2023
Q2 		$172K Buy
22,800
+951
+4% +$7.71K 0.21% 218
2023
Q1 		$193K Buy
+21,849
New +$216K 0.08% 411

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AXQ Capital's TEVA Position: Q2 2024 in Review

AXQ Capital sold out of Teva Pharmaceuticals (TEVA) in Q2 2024, closing a stake of 15,600 shares — an estimated $220K sold.

AXQ Capital first reported a position in TEVA in Q1 2023 and held it in 5 quarters. The position peaked at $287K in Q3 2023. 533 funds tracked by Wall St. Rank hold TEVA as of Q2 2024.

  • AXQ Capital reported no remaining Teva Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • AXQ Capital sold 15,600 Teva Pharmaceuticals shares in Q2 2024, an estimated $220K.
  • AXQ Capital first reported a position in Teva Pharmaceuticals in Q1 2023 and held it in 5 quarters.
  • AXQ Capital's Teva Pharmaceuticals position peaked at $287K in Q3 2023.
  • 533 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2024.

Based on AXQ Capital's 13F filing for Q2 2024, filed 13 Aug 2024.